Hugo Geerts

5.8k total citations
141 papers, 4.5k citations indexed

About

Hugo Geerts is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Hugo Geerts has authored 141 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 48 papers in Cellular and Molecular Neuroscience and 35 papers in Physiology. Recurrent topics in Hugo Geerts's work include Alzheimer's disease research and treatments (33 papers), Computational Drug Discovery Methods (31 papers) and Neuroscience and Neuropharmacology Research (25 papers). Hugo Geerts is often cited by papers focused on Alzheimer's disease research and treatments (33 papers), Computational Drug Discovery Methods (31 papers) and Neuroscience and Neuropharmacology Research (25 papers). Hugo Geerts collaborates with scholars based in United States, Belgium and Netherlands. Hugo Geerts's co-authors include Rony Nuydens, Jan‐Mark Geusebroek, A.W.M. Smeulders, Äthan Spiros, Patrick J. Roberts, R. van den Boomgaard, M. De Brabander, Chris Van den Haute, Kurt Spittaels and Frans W. Cornelissen and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Hugo Geerts

134 papers receiving 4.3k citations

Peers

Hugo Geerts

PHYSI

CMN

PHARM

CTM

Guanghua Xiao United States

Xiaoqun Zhang China

Raymond Scott Turner United States

Seán Murphy United States

Tōru Yamada Japan

Jane Y. Wu United States

Steven R. Gullans United States

Ying Liu China

Nigel J. Cairns United States

George C. Tseng United States

Guanghua Xiao United States

Hugo Geerts

3.9k ×2.0

1.0k ×0.8

PHYSI

566 ×0.6

CMN

323 ×0.4

PHARM

112 ×0.2

CTM

Citations per year, relative to Hugo Geerts Hugo Geerts (= 1×) peers Guanghua Xiao

Countries citing papers authored by Hugo Geerts

Since Specialization

Citations

This map shows the geographic impact of Hugo Geerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Geerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Geerts more than expected).

Fields of papers citing papers by Hugo Geerts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Geerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Geerts. The network helps show where Hugo Geerts may publish in the future.

Co-authorship network of co-authors of Hugo Geerts

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Geerts. A scholar is included among the top collaborators of Hugo Geerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Geerts. Hugo Geerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geerts, Hugo, et al.. (2023). Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases. Journal of Pharmacokinetics and Pharmacodynamics. 51(5). 563–573. 1 indexed citations

Geerts, Hugo, Piet H. van der Graaf, Edgar Schuck, et al.. (2023). A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease. CPT Pharmacometrics & Systems Pharmacology. 12(4). 444–461. 13 indexed citations

Kadra-Scalzo, Giouliana, Äthan Spiros, Hitesh Shetty, et al.. (2018). Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare. Journal of Psychopharmacology. 32(11). 1191–1196. 8 indexed citations

Geerts, Hugo, Äthan Spiros, Patrick J. Roberts, & Larry Alphs. (2018). A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthly. Schizophrenia Research. 197. 261–268. 7 indexed citations

Geerts, Hugo, Äthan Spiros, & Patrick J. Roberts. (2018). Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model. Alzheimer s Research & Therapy. 10(1). 14–14. 28 indexed citations

Roberts, Patrick J., Äthan Spiros, & Hugo Geerts. (2016). A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson’s Disease. Frontiers in Pharmacology. 7. 6–6. 30 indexed citations

Spiros, Äthan, Patrick J. Roberts, & Hugo Geerts. (2014). A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance. Frontiers in Pharmacology. 5. 229–229. 13 indexed citations

Spiros, Äthan, Robert Carr, & Hugo Geerts. (2010). Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse. SHILAP Revista de lepidopterología. 10 indexed citations

Sellal, François, André Nieoullon, Bernard François Michel, et al.. (2005). Pharmacology of Alzheimer’s Disease: Appraisal and Prospects. Dementia and Geriatric Cognitive Disorders. 19(5-6). 229–245. 6 indexed citations

10.

Geerts, Hugo, et al.. (2002). The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. Journal of the Neurological Sciences. 203-204. 131–136. 46 indexed citations

11.

Geerts, Hugo, et al.. (2002). Nicotinic receptor modulation: Advantages for successful Alzheimer’s disease therapy. Journal of neural transmission. Supplementum. 203–216. 32 indexed citations

12.

Spittaels, Kurt, Chris Van den Haute, Jo Van Dorpe, et al.. (2000). Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice. Journal of Biological Chemistry. 275(52). 41340–41349. 272 indexed citations

13.

Spittaels, Kurt, Chris Van den Haute, Jo Van Dorpe, et al.. (1999). Prominent Axonopathy in the Brain and Spinal Cord of Transgenic Mice Overexpressing Four-Repeat Human tau Protein. American Journal Of Pathology. 155(6). 2153–2165. 315 indexed citations

14.

Nuydens, Rony, et al.. (1998). Altered [Ca2+] homeostasis in PC12 cells after nerve growth factor deprivation. Brain Research. 779(1-2). 350–353. 3 indexed citations

15.

Nuydens, Rony, et al.. (1995). Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity. Neurobiology of Aging. 16(3). 465–475. 10 indexed citations

16.

Murase, K., et al.. (1994). Sabeluzole Potentiates the Effect of Nerve Growth Factor on Survival and Differentiation in PC12 Cells and Sympathetic Neurons.. 43. 112. 1 indexed citations

17.

Nuydens, Rony, et al.. (1993). The fast axonal transport in hippocampal neurones is acutely enhanced by db-cAMP. Neuroreport. 4(2). 179–182. 8 indexed citations

18.

Olbrich, H. G., Hugo Geerts, Luc Ver Donck, Gisbert Kober, & M. Kaltenbach. (1991). Cyclosporine A increases the intracellular free calcium concentration in electrically paced isolated rat cardiomyocytes. Journal of the American College of Cardiology. 17(2). A140–A140. 3 indexed citations

19.

Olbrich, H. G., Hugo Geerts, E. Mutschler, et al.. (1991). THE EFFECT OF CYCLOSPORINE ON ELECTRICALLY PACED ISOLATED RAT CARDIOMYOCYTES. Transplantation. 51(5). 972–976. 11 indexed citations

20.

Cornelissen, Frans W., et al.. (1990). Automatic quantification of fast axonal transport in neuronal cell cultures. Journal of Neuroscience Methods. 35(1). 79–88. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact